Hydroxytyrosol, a natural molecule from olive oil, suppresses the growth of human hepatocellular carcinoma cells via inactivating AKT and nuclear factor-kappa B pathways-Reference-Cited by-同舟云学术

Hydroxytyrosol, a natural molecule from olive oil, suppresses the growth of human hepatocellular carcinoma cells via inactivating AKT and nuclear factor-kappa B pathways

Published:2014-05 Issue:1 Volume:347 Page:79-87
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Zhao Baolei,Ma Yong,Xu Zhilin,Wang Jizhou,Wang Fengjun,Wang Dawei,Pan Shangha,Wu Yaohua,Pan Huayang,Xu Dongsheng,Liu Lianxin,Jiang Hongchi

Funder

Heilongjiang Postdoctoral Foundation

China Postdoctoral Science Foundation

Natural Science Foundation of Heilongjiang Province of China

National Natural Scientific Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference39 articles.

1. Cancer statistics;Siegel;CA Cancer J. Clin.,2012

2. Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma;Chen;BMC Gastroenterol.,2011

3. Hepatocellular carcinoma;Forner;Lancet,2012

4. Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?;Asghar;J. Hepatol.,2012

5. Active components and clinical applications of olive oil;Waterman;Altern. Med. Rev.,2007

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Olive Leaves as a Source of Anticancer Compounds: In Vitro Evidence and Mechanisms;Molecules;2024-09-07

2. Hydroxytyrosol isolation, comparison of synthetic routes and potential biological activities;Food Science & Nutrition;2024-07-16

3. Anti-Cancer, Anti-Angiogenic, and Anti-Atherogenic Potential of Key Phenolic Compounds from Virgin Olive Oil;Nutrients;2024-04-25

4. Mediterranean diet in the targeted prevention and personalized treatment of chronic diseases: evidence, potential mechanisms, and prospects;EPMA Journal;2024-04-16

5. Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine;Biomedicines;2024-02-23